三缺位硅钨酸盐纳米材料的调控形貌的合成及功能化

以三缺位Keggin型硅钨酸盐为前驱体,采用化学沉淀法成功合成出2例新型纳米材料M_3SiW_9(M=Cu.,Co.)。其中,Cu_3SiW_9表现为新颖的纳米晶须形貌,Co_3SiW_9表现为尺寸均一的球形纳米颗粒。经过一系列控制实验证明,通过掺杂不同类型的金属离子可以调控M_3SiW_9的形貌。我们对产生该现象的机理进行了合理推测。此外,使用荧光素钠作为掺杂剂可使Cu_3SiW_9纳米晶须具有优良的光致发光性能,测试表明,多酸并未淬灭荧光素钠的发光,复合材料在510 nm具有明显的发射波长。最后,我们对Cu_3SiW_9纳米晶须负载CdS量子点后的光催化产氢性质进行了研究。结果表明,当Cu_3SiW_9与CdS的质量比为1∶1时,复合材料的产氢效率约为纯CdS量子点的10倍。这也证实多金属氧酸盐的存在可以有效抑制CdS量子点光生电子与空穴的复合,从而大幅提高其光解水产氢的效率。     

Rational design of perfluorinated sulfonic acid ionic sieve modified separator for high-performance Li-S battery

Journal of Solid State Electrochemistry - Practical application of Li-S battery is limited by the fast capacity decay and low coulombic efficiency caused by the shuttling phenomenon. Modification...     

新型稀磁半导体Fe掺杂LiZnP的光电性质

采用基于密度泛函理论的第一性原理计算法研究了新型稀磁半导体Li_(1±)_y(Zn_(1-)_xFe_x)P (x=0, 0.0625;y=0, 0.0625)的电子结构、磁性及光学性质.结果表明,Fe的掺入使体系产生自旋极化杂质带,Fe的3d态与Li2s态,Zn4s态以及P3p态的态密度峰在费米能级处出现重叠,产生sp-d轨道杂化,此时体系净磁矩最大,材料表现出金属性,导电性增强.当Li空位时,导电性减弱,但杂质带宽度最大,居里温度最高.而Li填隙时,体系形成能最低,材料变为半金属性,表现为100%自旋注入,表明掺杂体系的磁性和电性可以分别通过Fe的掺入和Li的含量进行调控.对比光学性质发现,Li空位时,在介电函数虚部和复折射率函数的低能区出现新峰,扩大了对低频电磁波的吸收范围.能量损失函数表明掺杂体系具有明显的蓝移效应,且Li填隙时有更强的等离子共振频率.     

皮肤组织容积脉搏波400~1000 nm光谱特性仿真研究

根据皮肤组织解剖结构特性建立了六层层状模型,并给出了皮肤组织各层的特性参数;考虑了氧合血红蛋白和还原血红蛋白的吸收特性,依据皮肤组织各层的水、血、脂肪、血氧饱和度含量以及血管大小给出了皮肤组织各层的光谱吸收系数;对不同波长散射系数做了适当简化,给出了皮肤组织各层的光谱散射系数。利用蒙特卡罗方法仿真血管组织在收缩与舒张两种状态下, 400~1 000 nm波长光在皮肤组织多层模型中的传输过程,并通过统计大量光子的分布特性,获得了皮肤组织光谱反射系数,并利用模拟所得的两种状态下的反射系数计算得到了光谱容积脉搏波幅度。仿真结果表明,当入射光强一定时,绿光的容积脉搏波幅度优于红光和蓝光。通过计算不同波长光沿皮肤组织深度方向光能流率衰减为1/e时对应的皮肤组织深度,获得了皮肤组织光谱穿透深度。结果显示,血管舒张状态下蓝光和绿光的穿透深度较小,蓝光大部分只能达到表皮层,绿光能到达微循环层,红光可直达真皮层。考虑到光在皮肤组织中传播包含了一个从收缩到舒张的动态过程,基于此,根据穿透深度定义了脉搏波信号产生深度,利用血管舒张与收缩两种不同状态下的穿透深度计算得到了光谱产生深度。结果表明,不同波长光产生深度大于其穿透深度,蓝光产生深度较浅,且其受到的血液吸收调制较小,因而其获得的脉搏信号易受噪声干扰;红光的容积脉搏波产生深度较大,但是相比于绿光其受血液吸收调制较小,且绿光产生深度足够达到真皮血管层,因而红光容积脉搏波的幅度小于绿光。上述仿真结果明确了皮肤组织部分光谱特性,为皮肤组织多光谱容积脉搏波的精确获取及其他相关研究提供了一定的理论基础。     

Pharmacokinetic study of tanshinol and ligustrazine in rat plasma after intravenous administration of tanshinol and Danshen Chuanxiongqin Injection

To investigate the effect of ligustrazine on the pharmacokinetic profile of tanshinol after intravenous administration in rats, a sensitive liquid chromatography tandem mass spectrometry method was developed and validated for quantitative determination of tanshinol and ligustrazine in rat plasma. After prepared by protein precipitation, the analytes were separated on a Waters Acquity HSS T3 column (100 × 2.1 mm, 1.8μm) and eluted by 0.1% formic acid in water and acetonitrile at a flow rate of 0.4 ml/min. The precursor–product ion transitions were m/z 197.0 → 135.0 for tanshinol, m/z 417.1 → 255.1 for liquiritin (internal standard) in negative ion mode and m/z 137.1 → 55.0 for ligustrazine in positive ion mode. To avoid the interference of tanshinol metabolite transformation, the stability of analytes in samples collected after administration was assessed. The validated method was successfully applied to a pharmacokinetic study after intravenous administration of single tanshinol and Danshen Chuanxiongqin Injection. After Danshen Chuanxiongqin injection administration, the values of elimination half-time, area under the concentration–time curve and C_o were 0.36 ± 0.13 h, 1.29 ± 0.37 μg/ml h and 10.51 ± 2.58 μg/ml for male rats, respectively. In the single tanshinol group, the corresponding values were 0.56 ± 0.24 h, 1.85 ± 0.44 μg/ml h and 14.11 ± 2.26 μg/ml for male rats—30–40% higher than those for the Danshen Chuanxiongqin Injection group. There was a significant different between male and female rats. This study provided information on the influence of ligustrazine on the pharmacokinetic characteristics of tanshinol after intravenous administration of Danshen Chuanxiongqin Injection in rats, which will be helpful for its clinical application.     

Unlocking the Drug Potential of the Bryostatin Family: Recent Advances in Product Synthesis and Biomedical Applications

Bryostatins are a class of naturally occurring macrocyclic lactones with a unique fast developing portfolio of clinical applications, including treatment of AIDS, Alzheimer's disease, and cancer. This comprehensive account summarizes the recent progress (2014–present) in the development of bryostatins, including their total synthesis and biomedical applications. An emphasis is placed on the discussion of bryostatin 1 , the most-studied analogue to date. This review highlights the synthetic and biological challenges of bryostatins and provides an outlook on their future development.     

Yb3+掺杂稀土钽铌酸盐的晶体场从头计算研究

Yb³⁺掺杂晶体材料是重要的激光材料,在超短脉冲激光、大功率激光等领域有重要应用前景,但长期以来很难通过实验拟合确定Yb3+晶体场参数,尤其是低对称体系,从头计算是解决此问题的重要途经.本文介绍了适合计算稀土离子掺杂晶体的从头计算DV-Xα方法和有效哈密顿量模型,用该方法计算了Yb³⁺掺杂M型和M'型钽铌酸盐的晶场参数和旋轨耦合参数,得到的能级结构和实验能很好地符合,并发现了Yb³⁺掺杂钽铌酸盐的晶场强度参数随稀土原子序数呈现规律变化.表明结合DV-Xα计算和有效哈密顿量方法是计算Yb³⁺掺杂低对称钽铌酸盐晶体场的有效途径,结果显示Yb3+掺杂钽铌酸盐晶体有望成为新型全固态激光工作物质.     

中红外激光陶瓷的研究进展与展望

波段为2～5tμm的中红外激光在国防、医疗、通信等方面有着特殊的重要应用,而直接产生中红外激光的增益介质主要包括气体激光介质、半导体、稀土离子或者过渡金属离子掺杂的化合物.本文首先介绍应用于中红外波段的发光离子(包括Tm3,Ho3+,Er3+等稀土离子和Cr2+,Fe2等过渡金属离子)光谱特性,然后重点介绍氧化物(包括石榴石和倍半氧化物)和Ⅱ-Ⅵ族化合物(主要是ZnS/ZnSe)两大类中红外激光陶瓷材料的制备与激光性能.最后,对这两大类中红外激光陶瓷中存在的问题进行了分析,并对其发展方向进行了展望.     

分数阶Schrodinger—Kirchhoff方程无穷多高能量解的存在性

本文研究如下带有变号势函数的分数阶Schrodinger Kirchhoff方程(a+b∫∫R^N|u(x)-u(y)|^p/|x-y|^N+p^sdxdy)^p-1(-△)p^su+λV(x)|u|^p-2u=f(x,u)-μg(x)|u|^q-2u,x∈R^N.其中s∈(0,1),p∈[2,∞),q∈(l,p),a,b>0,λ,μ>0均为正常数,在V,f,g等函数合适的条件下,运用喷泉定理获得该系统无穷多高能量解的存在性.     

微极流体方程组在Besov空间中弱解的正则性准则

In this paper,we investigate the regularity criterion via the pressure of weak solutions to the micropolar fluid equations in three dimensions.We obtain that for 0<α<1 if p€L^2/a(0,T;B^α∞,∞),then the weak solution(u,ω)is regular on(0,T).